Madeline Polak

9PUBLICATIONS
55CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 30, 2026
Transcriptional signatures indicating RB function correlate with response to CDK4/6 inhibition in endometrial cancer.

|Mar 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.

Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir

|Dec 03, 2025
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial.

Panagiotis A Konstantinopoulos, Ningxuan Zhou, Richard T Penson

|Apr 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.

Panagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee

|Apr 18, 2024
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses.

Panagiotis A Konstantinopoulos, Su-Chun Cheng, Elizabeth K Lee

|Sep 29, 2022
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer.

Panagiotis A Konstantinopoulos, Elizabeth K Lee, Niya Xiong

Pageof 2

Frequent Collaborators

8 joint publications

Panagiotis A Konstantinopoulos

6 joint publications

Elizabeth K Lee

6 joint publications

Ursula A Matulonis

3 joint publications

David L Kolin